138 related articles for article (PubMed ID: 11947964)
1. Autonomic neuropathy in streptozotocin diabetic rats: effect of acetyl-L-carnitine.
Lo Giudice P; Careddu A; Magni G; Quagliata T; Pacifici L; Carminati P
Diabetes Res Clin Pract; 2002 Jun; 56(3):173-80. PubMed ID: 11947964
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-carnitine effects on nerve conduction and glycemic regulation in experimental diabetes.
Soneru IL; Khan T; Orfalian Z; Abraira C
Endocr Res; 1997; 23(1-2):27-36. PubMed ID: 9187536
[TBL] [Abstract][Full Text] [Related]
3. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
Malone JI; Lowitt S; Corsico N; Orfalian Z
Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Heart Rate Variability and Cardiac Autonomic Nerve Remodeling in Streptozotocin-induced Diabetic Rats.
Li X; Jiang YH; Jiang P; Lin HQ; Yang JL; Ma DF; Wang X; Yang CH
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):272-81. PubMed ID: 25962404
[TBL] [Abstract][Full Text] [Related]
5. Gabapentin therapy improves heart rate variability in diabetic patients with peripheral neuropathy.
Ermis N; Gullu H; Caliskan M; Unsal A; Kulaksizoglu M; Muderrisoglu H
J Diabetes Complications; 2010; 24(4):229-33. PubMed ID: 19195912
[TBL] [Abstract][Full Text] [Related]
6. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy.
Burger AJ; Weinrauch LA; D'Elia JA; Aronson D
Am J Cardiol; 1999 Sep; 84(6):687-91. PubMed ID: 10498140
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy.
Kontopoulos AG; Athyros VG; Didangelos TP; Papageorgiou AA; Avramidis MJ; Mayroudi MC; Karamitsos DT
Diabetes Care; 1997 Mar; 20(3):355-61. PubMed ID: 9051387
[TBL] [Abstract][Full Text] [Related]
8. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
Marzo A; Corsico N; Cardace G; Morabito E
Arzneimittelforschung; 1993 Mar; 43(3):339-42. PubMed ID: 8489564
[TBL] [Abstract][Full Text] [Related]
9. Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.
Gorio A; Di Giulio AM; Tenconi B; Donadoni L; Germani E; Bertelli A; Mantegazza P; Maccari F; Ramacci MT
Int J Clin Pharmacol Res; 1992; 12(5-6):225-30. PubMed ID: 1284498
[TBL] [Abstract][Full Text] [Related]
10. Effect of acetyl-L-carnitine on VIP-ergic neurons in the jejunum submucous plexus of diabetic rats.
Defani MA; Zanoni JN; Natali MR; Bazotte RB; de Miranda-Neto MH
Arq Neuropsiquiatr; 2003 Dec; 61(4):962-7. PubMed ID: 14762599
[TBL] [Abstract][Full Text] [Related]
11. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.
Lowitt S; Malone JI; Salem AF; Korthals J; Benford S
Metabolism; 1995 May; 44(5):677-80. PubMed ID: 7752919
[TBL] [Abstract][Full Text] [Related]
12. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N
J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270
[TBL] [Abstract][Full Text] [Related]
13. Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes.
Cotter MA; Cameron NE; Keegan A; Dines KC
Metabolism; 1995 Sep; 44(9):1209-14. PubMed ID: 7666797
[TBL] [Abstract][Full Text] [Related]
14. Assessment of diabetic autonomic neuropathy using twenty-four-hour spectral analysis of heart rate variability: a comparison with the findings of the Ewing battery.
Takase B; Kitamura H; Noritake M; Nagase T; Kurita A; Ohsuzu F; Matsuoka T
Jpn Heart J; 2002 Mar; 43(2):127-35. PubMed ID: 12025899
[TBL] [Abstract][Full Text] [Related]
15. Preventive effect of acetyl-L-carnitine on the thermal hypoalgesia in streptozotocin-induced diabetic mice.
Ohsawa M; Miyata S; Carlsson A; Kamei J
Eur J Pharmacol; 2008 Jul; 588(2-3):213-6. PubMed ID: 18501889
[TBL] [Abstract][Full Text] [Related]
16. Autonomic neuropathy in the alloxan-diabetic rat.
Tomlinson DR; Yusof AP
J Auton Pharmacol; 1983 Dec; 3(4):257-63. PubMed ID: 6662852
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine release in experimental autonomic neuropathy.
Uccioli L; Magnani P; Tilli P; Cotroneo P; Manto A; Mancini L; Monticone G; Greco AV; Menzinger G; Ghirlanda G
Funct Neurol; 1991; 6(3):231-3. PubMed ID: 1743533
[TBL] [Abstract][Full Text] [Related]
18. Heart rate variability in diabetic patients during orthostatic load--a spectral analytic approach.
Weise F; Heydenreich F; Gehrig W; Runge U
Klin Wochenschr; 1990 Jan; 68(1):26-32. PubMed ID: 2155343
[TBL] [Abstract][Full Text] [Related]
19. Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction.
Murça TM; Almeida TC; Raizada MK; Ferreira AJ
Exp Physiol; 2012 Jun; 97(6):699-709. PubMed ID: 22286369
[TBL] [Abstract][Full Text] [Related]
20. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ
Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
